The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Glaxo Smith Kline has sued Abbott Laboratories for increasing its AIDS drug Norvir, five-fold. Norvir, approved by the FDA in 1996, is known as a protease inhibitor. Abbott is also being sued by 2 AIDS patients as well as the SEIU Health and Welfare Fund. This suit has been classified as a class action. According to Glaxo, the quintuple increase in drug price undercut Glaxo’s Lexiva, another AIDS drug.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest